Peter Behner
Independent DirectorMr. Peter Behner is Non-Employee Director of Mink Therapeutics Inc. since April 2021. Since July 2020, Mr. Behner has served as Global Health Sciences & Wellness Strategy and Transactions Leader at Ernst & Young. Mr. Behner joined Ernst & Young in September 2018 as the Global Transaction Services Leader for the Pharmaceutical and Life Sciences Industries. From 2013 to June 2018, Mr. Behner was European Head of Health Industries and Consulting Leader for the Pharma & Lifesciences Industries for the EMEA region for Strategy&, a PricewaterhouseCoopers (PwC) company. From 2005 until its 2013 acquisition by PwC, Mr. Behner was an equity partner at Booz & Company (BC), together with Booz Allen Hamilton (BAH), prior to BC’s spin-out from BAH. From 2003 to 2005, Mr. Behner was a partner at A.T. Kearney in its German Division and from 2004 to 2005, he was Head of A.T. Kearney’s European Pharmaceutical and Life Science Industry group. Additionally, since April 2015, Mr. Behner has served as a Principal of Rottendorf GmbH, a pharmaceutical contract development and manufacturing company. He holds a combined B.E. & M.E. degree in Mechanical Engineering for RWTH Aachen University in Germany. Mr. Behner currently works part-time as a non-equity based Operating Partner at Armira Partners GmbH, a German private equity firm as Managing Director of BEMA1 GmbH, a Germany-based real estate investment firm.
公司職務
- 公司名稱MiNK Therapeutics, Inc.股票代碼INKT職務Independent Director共事同僚
- GHGaro H. ArmenExecutive Chairman
- JSJennifer S. BuellCo-Founder, President, CEO & Director
- MOMelissa OrilallPrincipal Financial Officer
- ACAustin CharettePrincipal Accounting Officer
- TCTerese C. HammondHead of Inflammatory & Pulmonary Diseases
- BJBrian J. CorveseIndependent Director
- BABarbara A. RyanIndependent Director
